Clot composition of embolic strokes of undetermined source: a feasibility study.


Journal

BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555

Informations de publication

Date de publication:
21 Oct 2020
Historique:
received: 18 05 2020
accepted: 19 10 2020
entrez: 22 10 2020
pubmed: 23 10 2020
medline: 22 1 2021
Statut: epublish

Résumé

A number of emerging studies have evaluated clot composition in acute ischemic stroke. Studies of clot composition of embolic strokes of undetermined strokes are lacking. We sought to analyze the RBC to platelet ratios in clots and correlated our findings with stroke etiology. This was a prospective study analyzing clots retrieved by mechanical thrombectomy in acute ischemic stroke patients at our institution. All clots were stained and scanned at 200x magnification by using a Scanscope XT digital scanner (Apergio, Vista, California). Image-J software (National Institutes of Health, Bethesda, Maryland) was used for semi quantitative analysis of percentage RBC's and platelets. Unpaired t-test was used to compare means of RBC to Platelet ratios. Correlation of RBC to Platelet ratios with stroke etiology was performed. A total of 33 clots from 33 patients were analyzed. Stroke etiology was undetermined in 6 patients, cardioembolic in 14, large vessel atherosclerosis (LVA) in 9, and carotid dissection in 4. The mean RBC to platelet ratio was 0.78:1 (+/- 0.65) in cardioembolic clots, 1.73:1 (+/- 2.38) in LVA and 1.4:1(+/- 0.70) in carotid dissections. Although patients with undetermined etiology had a similar clot composition to cardioembolic stroke (0.36:1+/- 0.33), (p = 0.19), it differed significantly from LVA and dissections respectively (p = 0.037, p = 0.01). In our study, a low RBC to Platelet ratio was found among patients with embolic strokes of undetermined source, however shared similar characteristics with cardioembolic thrombi. Ongoing collection and analysis is needed to confirm these findings and its significance in evaluating stroke etiology.

Sections du résumé

BACKGROUND BACKGROUND
A number of emerging studies have evaluated clot composition in acute ischemic stroke. Studies of clot composition of embolic strokes of undetermined strokes are lacking.
OBJECTIVES OBJECTIVE
We sought to analyze the RBC to platelet ratios in clots and correlated our findings with stroke etiology.
METHODS METHODS
This was a prospective study analyzing clots retrieved by mechanical thrombectomy in acute ischemic stroke patients at our institution. All clots were stained and scanned at 200x magnification by using a Scanscope XT digital scanner (Apergio, Vista, California). Image-J software (National Institutes of Health, Bethesda, Maryland) was used for semi quantitative analysis of percentage RBC's and platelets. Unpaired t-test was used to compare means of RBC to Platelet ratios. Correlation of RBC to Platelet ratios with stroke etiology was performed.
RESULTS RESULTS
A total of 33 clots from 33 patients were analyzed. Stroke etiology was undetermined in 6 patients, cardioembolic in 14, large vessel atherosclerosis (LVA) in 9, and carotid dissection in 4. The mean RBC to platelet ratio was 0.78:1 (+/- 0.65) in cardioembolic clots, 1.73:1 (+/- 2.38) in LVA and 1.4:1(+/- 0.70) in carotid dissections. Although patients with undetermined etiology had a similar clot composition to cardioembolic stroke (0.36:1+/- 0.33), (p = 0.19), it differed significantly from LVA and dissections respectively (p = 0.037, p = 0.01).
CONCLUSION CONCLUSIONS
In our study, a low RBC to Platelet ratio was found among patients with embolic strokes of undetermined source, however shared similar characteristics with cardioembolic thrombi. Ongoing collection and analysis is needed to confirm these findings and its significance in evaluating stroke etiology.

Identifiants

pubmed: 33087070
doi: 10.1186/s12883-020-01969-w
pii: 10.1186/s12883-020-01969-w
pmc: PMC7580014
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

383

Références

Stroke. 2017 Aug;48(8):2206-2210
pubmed: 28626055
Circulation. 2018 Apr 24;137(17):1767-1769
pubmed: 29348262
Stroke. 2006 Aug;37(8):2086-93
pubmed: 16794209
Ann Neurol. 2015 Nov;78(5):670-8
pubmed: 26179566
Stroke. 2016 Jul;47(7):1864-71
pubmed: 27197854
J Neurointerv Surg. 2019 Sep;11(9):884-890
pubmed: 30760625
Stroke. 2018 Mar;49(3):734-737
pubmed: 29371431
Int J Stroke. 2017 Aug;12(6):606-614
pubmed: 28534706
Stroke. 2013 Apr;44(4):961-7
pubmed: 23471272
Stroke. 2018 Mar;49(3):e46-e110
pubmed: 29367334
Stroke. 2018 Mar;49(3):652-659
pubmed: 29374103
Stroke. 2015 Aug;46(8):2087-93
pubmed: 26159795
Stroke. 2019 Mar;50(3):697-704
pubmed: 30776994
J Stroke Cerebrovasc Dis. 2017 Oct;26(10):2416-2420
pubmed: 28666806
J Neurointerv Surg. 2017 Jun;9(6):529-534
pubmed: 27166383
J Neuroradiol. 2015 Apr;42(2):86-92
pubmed: 24560545
J Stroke Cerebrovasc Dis. 2018 Jun;27(6):1497-1501
pubmed: 29398537
AJNR Am J Neuroradiol. 2015 Sep;36(9):1756-62
pubmed: 26159515
Haematologica. 2020 Jan 31;105(2):498-507
pubmed: 31048352
Lancet Neurol. 2014 Apr;13(4):429-38
pubmed: 24646875
Stroke. 2014 Jun;45(6):1646-50
pubmed: 24757103
Stroke. 2017 Aug;48(8):2040-2041
pubmed: 28626053
Stroke. 2012 Aug;43(8):2036-41
pubmed: 22627989
N Engl J Med. 2014 Jun 26;370(26):2467-77
pubmed: 24963566
Front Neurol. 2016 Mar 21;7:37
pubmed: 27047443

Auteurs

Amre Nouh (A)

Department of Neurology, Hartford Hospital, University of Connecticut, 80 Seymour Street, Hartford, CT, 06115, USA. amre.nouh@hhchealth.org.

Tapan Mehta (T)

Department of Neurology, Hartford Hospital, University of Connecticut, 80 Seymour Street, Hartford, CT, 06115, USA.
Department of Neurology, University of Minnesota, Minneapolis, MN, USA.

Mohamed Hussain (M)

Department of Neurology, Hartford Hospital, University of Connecticut, 80 Seymour Street, Hartford, CT, 06115, USA.
Department of Neuroradiology, Hartford Hospital, University of Connecticut, Hartford, CT, USA.

Xianyuan Song (X)

Department of Pathology, Hartford Hospital, University of Connecticut, Hartford, CT, USA.

Martin Ollenschleger (M)

Department of Neuroradiology, Hartford Hospital, University of Connecticut, Hartford, CT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH